84
Participants
Start Date
June 14, 2024
Primary Completion Date
May 22, 2025
Study Completion Date
June 16, 2025
RE104 for Injection
Single, subcutaneous dose of RE104 for Injection
Reunion Investigational Site, New York
Reunion Investigational Site, New York
Reunion Investigational Site, Buffalo
Reunion Investigational Site, West Chester
Reunion Investigational Site, Rockville
Reunion Investigational Site, Baltimore
Reunion Investigational Site, Charlottesville
Reunion Investigational Site, Chapel Hill
Reunion Investigational Site, Monroe
Reunion Investigational Site, Decatur
Reunion Investigational Site, Marietta
Reunion Investigational Site, Atlanta
Reunion Investigational Site, Atlanta
Reunion Investigational Site, Savannah
Reunion Investigational Site, Lauderhill
Reunion Investigational Site, Tampa
Reunion Investigational Site, Birmingham
Reunion Investigational Site, Columbus
Reunion Investigational Site, Cleveland
Reunion Investigational Site, Novi
Reunion Investigational Site, Madison
Reunion Investigational Site, Kansas City
Reunion Investigational Site, Shreveport
Reunion Investigational Site, Plano
Reunion Investigational Site, San Antonio
Reunion Investigational Site, Austin
Reunion Investigational Site, Austin
Reunion Investigational Site, Austin
Reunion Investigational Site, Boulder
Reunion Investigational Site, Denver
Reunion Investigational Site, Draper
Reunion Investigational Site, Salt Lake City
Reunion Investigational Site, Tucson
Reunion Investigational Site, Albuquerque
Reunion Investigational Site, Santa Monica
Reunion Investigational Site, Honolulu
Reunion Investigational Site, Seattle
Reunion Investigational Site, Springfield
Reunion Neuroscience Inc
INDUSTRY